BioSpace News Archive

Pharm Country

Visiox Pharma Announces Close of $7M Seed Round

Visiox Pharma, LLC today announced the closing of a $7M seed round of financing.

August 3, 2022
·
2 min read
Integrity Laboratories, LLC Announces Monkeypox Validation

Integrity Laboratories, LLC has completed the validation for the Monkeypox virus PCR test. The test is now available for immediate order by clinicians.

August 3, 2022
·
1 min read
FDA

FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition

Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of JUVÉDERM ® VOLUX™ XC for the improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition.

August 3, 2022
·
10 min read
Study: Plant-Based Synthetic Organs Prove Effective for Fluorescence-Guided Surgical Training

A new study on the effectiveness of plant-based organs for use in surgical training was performed by Dr. Naoki Nishio at the Nagoya University Graduate School of Medicine.

August 3, 2022
·
2 min read
Genetown

Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference

Praxis Precision Medicines , Inc. today announced that management will participate in the “Got My Mind Set On You – Advancing Novel Epilepsy Targets” panel at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 at 12:35 p.m. ET.

August 3, 2022
·
1 min read
Biotech Beach

Biora Therapeutics Announces Five Abstracts Accepted at American College of Gastroenterology Annual Scientific Meeting 2022

Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced the acceptance of five abstracts for presentation at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting.

August 3, 2022
·
4 min read
Drug Development

Sorrento Completes Successfully the SAD Study and Initiates the MAD Phase 1 Study with STI-1558, An Oral M(pro) Inhibitor as a Standalone Treatment and Prevention of COVID-19 without the Ritonavir as Booster

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced the completion of the SAD portion of the Phase 1 study of its oral main viral protease (Mpro) inhibitor, the STI-1558.

August 3, 2022
·
6 min read
Business

NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode

NeuroOne Medical Technologies Corporation today announced that the Company entered into an amendment to its Exclusive Development and Distribution Agreement with Zimmer Biomet, Inc.

August 3, 2022
·
4 min read
Brand Institute President of Nonproprietary Naming Division Advises Clients on Guidance Set Forth by INN Regarding COVID-19 Variant Vaccines

Brand Institute’s President of its Nonproprietary Naming Division, Sophia Fuerst, M.S., M.B.A., is pleased to offer summary insights regarding recently implemented procedures for international nonproprietary names (INNs), specifically INNs for Variant COVID-19 Vaccine Active Substances.

August 3, 2022
·
2 min read
BioMidwest

Zynex Ranked in Top 50 Public Companies in Colorado

Zynex, Inc. announced the Denver Business Journal has ranked Zynex number 50 in a list Colorado-based public companies, according to 2021 revenue figures.

August 3, 2022
·
1 min read